Breast Cancer Treatment Market Size, Share, Trends, Growth Analysis, And Industry Forecast To 2022: Credence Research
The breast cancer treatment market was valued at USD 10,682.6 Mn in 2015, and is expected to reach USD 17,345.8 Mn by 2022, expanding at a CAGR of 7.6% from 2016 to 2022
(firmenpresse) - The latest market report published by Credence Research, Inc.rom 2016 to 2022.
Browse the full
Market Insights:
Breast cancer is typically detected either during a screening examination, before symptoms have developed, or after a woman notices a lump. According to market experts, breast cancer is the second-largest cause of cancer deaths globally. The rising prevalence of breast cancer across the developed nations has boosted the involvement of non-governmental associations that are spreading awareness related to breast cancer diagnostics and treatment in public. Therapeutic treatment preferred to treat breast cancer involves synthetic to biological drugs. The awareness created around the world in last decade has assisted the market growth along with market introduction of premium priced therapies. Moreover, drugs for breast cancer have seen accelerated approvals, thereby providing impetus for breast cancer research and shifting the equilibrium toward research of new effective pathways for intervention of breast cancer. On the other hand, the geographical analysis of breast cancer treatment market projected North America and Europe as the dominant regions followed by Asia-Pacific.l lead to significant market growth during the forecast period, despite generic sales erosion resulting from patent expirations.
Pipeline Analysis:
The phase III drugs included in the pipeline analysis are Abemaciclib (Eli Lily & Company), Buparlisib (Novartis), NeuVax (Galena Biopharma), Niraparib (Tesaro), Lynparza (AstraZeneca), Veliparib (AbbVie), Neratinib (Puma Biotechnology), Ribociclib (Novartis) and others. According to market experts, these upcoming drugs assure to provide enhanced efficacy, shorter onset of action and fewer side effects as compared to the currently available breast cancer treatment. Thus, future commercialization of these molecules during the forecast period 2016
Key Market Movements:
North America
The recent market entry of novel drugs including Perjeta, a targeted therapy; Kadcyla, a human antibody-drug conjugate; and Halaven, a novel chemotherapeutic agent have boosted the overall growth of breast cancer treatment market
The companies have been able to develop efficient and commercially successful products by studying pathophysiology of breast cancer in detail, e.g. Herceptin, which is build on the existing scientific groundwork.
Browse For Full Report With Table of Content (at)
http://www.credenceresearch.com/report/breast-cancer-treatment-market
Market Insights:
About Us:
Credence Research
Contact:
Name: Chris Smith
Designation: Global Sales Manager
E-mail:
Ph: 1-800-361-8290
Web:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 05.02.2018 - 04:35 Uhr
Sprache: Deutsch
News-ID 1532222
Anzahl Zeichen: 4537
contact information:
Contact person: David Colin
Town:
San Jose
Phone: 18003618290
Kategorie:
Automotive
Typ of Press Release: bitte
type of sending: Veröffentlichung
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 597 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Breast Cancer Treatment Market Size, Share, Trends, Growth Analysis, And Industry Forecast To 2022: Credence Research
"
steht unter der journalistisch-redaktionellen Verantwortung von
Credence Research (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
